BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32989861)

  • 1. The effect of universal infant vaccination on the prevalence of hepatitis B immunity in adult solid organ transplant candidates.
    Koc ÖM; Kuypers D; Dupont LJ; Vos R; Van Keer JM; Van Cleemput J; Robaeys G; Oude Lashof A; Kramer M; Verleden G; Verbeek J; Nevens F
    J Viral Hepat; 2021 Jan; 28(1):105-111. PubMed ID: 32989861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
    Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
    Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Affecting the Development of an Antibody Response to Hepatitis B Immunization in Children With Intestinal Failure: Before and After Small Bowel Transplantation (With and Without Liver Graft).
    Craggs HM; Jackson P; Gupte G; Hartley J; Abdel-Hady M; Morton R; Beath S; Hogg L
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):1030-1036. PubMed ID: 26962060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus prevalence in first-time blood donors in Flanders, Belgium: Impact of universal vaccination and migration.
    De Brier N; Koc ÖM; De Buck E; Muylaert A; Nevens F; Vanbrabant M; Vandeloo J; Van Remoortel H; Robaeys G; Compernolle V
    Transfusion; 2021 Jul; 61(7):2125-2136. PubMed ID: 33955570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa.
    Amponsah-Dacosta E; Lebelo RL; Rakgole JN; Burnett RJ; Selabe SG; Mphahlele MJ
    J Med Virol; 2014 Jun; 86(6):918-24. PubMed ID: 24615635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period.
    Park NH; Chung YH; Lee HS
    Intervirology; 2010; 53(1):20-8. PubMed ID: 20068337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B infection control in Colombian Amazon after 15 years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
    Garcia D; Porras A; Rico Mendoza A; Alvis N; Navas MC; De La Hoz F; De Neira M; Osorio E; Valderrama JF
    Vaccine; 2018 May; 36(19):2721-2726. PubMed ID: 29609968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment.
    Hontelez JA; Hahné S; Koedijk FH; de Melker HE
    J Epidemiol Community Health; 2010 Oct; 64(10):890-4. PubMed ID: 19822551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-induced protection against hepatitis B in pediatric solid organ transplant patients.
    Ball M; Liverman R; Serluco A; Yildirim I
    Pediatr Transplant; 2021 May; 25(3):e13920. PubMed ID: 33217081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis.
    Klinger G; Chodick G; Levy I
    Vaccine; 2018 Apr; 36(17):2288-2292. PubMed ID: 29573878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of the hepatitis B vaccination in pediatric renal transplant recipients.
    Miller-Handley H; Paulsen G; Hooper DK; Lake M; Lazear D; Danziger-Isakov L
    Clin Transplant; 2018 May; 32(5):e13247. PubMed ID: 29603431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Universal Infant Hepatitis B Immunization on Reducing the Hepatitis B Carrier Rate in Pregnant Women.
    Su WJ; Chen SF; Yang CH; Chuang PH; Chang HF; Chang MH
    J Infect Dis; 2019 Aug; 220(7):1118-1126. PubMed ID: 30576506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study.
    Hiva S; Negar K; Mohammad-Reza P; Gholam-Reza G; Mohsen A; Ali-Asghar NG; Mohammed-Jafar S
    BMC Public Health; 2020 Jun; 20(1):920. PubMed ID: 32532228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.